Bisphenol F Exposure Induces Ovarian Ferroptosis via the ERβ–ATM–Ferritinophagy Axis

2026

Closed access Metadata (CSL-JSON)
DOI 10.1021/acs.jafc.6c08276
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Bisphenol F (BPF) has rapidly emerged as a primary substitute for bisphenol A (BPA) and a ubiquitous environmental contaminant, yet its reproductive toxicity remains poorly understood, particularly at low doses. Here, we demonstrate that oral exposure to BPF (as low as 250 μg/kg) induces ovarian hypertrophy, disrupted follicular architecture and cumulus-oocyte communication, and reduced serum estradiol and progesterone in mice by triggering ferroptosis. Integrating multiomics approaches, we identified NCOA4-mediated ferritinophagy as the central cellular driver of this process. In granulosa cells, pharmacologic inhibition of autophagy and gene silencing blocked NCOA4 phosphorylation, ferritin degradation, iron overload, and ferroptosis. Mechanistically, we reveal a new signaling axis wherein BPF promotes the physical interaction between membrane-associated ERβ and the kinase ATM. This interaction triggers ATM activation and subsequent phosphorylation of NCOA4, thereby accelerating ferritin degradation and iron overload. Structural analysis identifies G2296 as the critical interface residue; importantly, an ATM-G2296A point mutation disrupts the ERβ-ATM interaction and abolishes BPF-induced ferroptosis. These findings elucidate a distinct molecular mechanism of ovarian injury driven by low-dose BPF exposure, underscoring the urgent need to reassess the safety profiles of BPF-containing materials.